THTX
Theratechnologies Inc
$
2.610
- Overview
- Forecast
- Valuation
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
2.640
Open
2.610
VWAP
2.60
Vol
103.66K
Mkt Cap
63.91M
Low
2.570
Amount
269.49K
EV/EBITDA(TTM)
11.08
Total Shares
45.98M
EV
166.70M
EV/OCF(TTM)
--
P/S(TTM)
1.47
Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2025Q3
FY2025Q2
23.63M
-5.25%
--
--
21.69M
-3.6%
--
--
17.51M
-20.61%
--
--
Estimates Revision
The market is revising Downward the revenue expectations for Theratechnologies Inc. (THTX) for FY2025, with the revenue forecasts being adjusted by -2.2% over the past three months. During the same period, the stock price has changed by 36.79%.
Revenue Estimates for FY2025
Revise Downward
-2.2%
In Past 3 Month
Stock Price
Go Up
+36.79%
In Past 3 Month
2 Analyst Rating
53.26% Upside
Wall Street analysts forecast THTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for THTX is 4.00 USD with a low forecast of 4.00 USD and a high forecast of 4.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
53.26% Upside
Current: 2.610
Low
4.00
Averages
4.00
High
4.00
53.26% Upside
Current: 2.610
Low
4.00
Averages
4.00
High
4.00
Jones Trading
Justin Walsh
Strong Buy
to
Hold
Downgrades
n/a
2024-10-11
Reason
Jones Trading
Justin Walsh
Price Target
n/a
2024-10-11
Downgrades
Strong Buy
to
Hold
Reason
See All Ratings
Valuation Metrics
The current forward P/E ratio for Theratechnologies Inc (THTX.O) is 16.46, compared to its 5-year average forward P/E of 4.84. For a more detailed relative valuation and DCF analysis to assess Theratechnologies Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
N/A
5Y Average PE
4.84
Current PE
16.46
Overvalued PE
42.66
Undervalued PE
-32.98
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
N/A
5Y Average EV/EBITDA
122.69
Current EV/EBITDA
10.52
Overvalued EV/EBITDA
539.87
Undervalued EV/EBITDA
-294.50
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Fair
5Y Average PS
1.90
Current PS
1.36
Overvalued PS
3.09
Undervalued PS
0.71
Financials
Annual
Quarterly
FY2025Q1
YoY :
+17.23%
19.05M
Total Revenue
FY2025Q1
YoY :
-184.37%
1.90M
Operating Profit
FY2025Q1
YoY :
-102.61%
117.00K
Net Income after Tax
FY2025Q1
YoY :
-100.00%
0.00
EPS - Diluted
FY2025Q1
YoY :
+1062.06%
-19.85M
Free Cash Flow
FY2025Q1
YoY :
+21.09%
81.71
Gross Profit Margin - %
FY2025Q1
YoY :
+169.29%
-19.47
FCF Margin - %
FY2025Q1
YoY :
-102.21%
0.61
Net Margin - %
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
0.0
Volume
0
6-9
Months
0.0
Volume
0
0-12
Months
0.0
Volume
0
Bought
0-3
0
0.0
Volume
Months
3-6
0
0.0
Volume
Months
6-9
0
0.0
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
0.0
USD
0
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
0.0
USD
0
Bought
0-3
0
0.0
USD
Months
3-6
0
0.0
USD
Months
6-9
0
0.0
USD
Months
0-12
0
0.0
USD
Months
THTX News & Events
Events Timeline
2025-04-15 (ET)
2025-04-15
18:01:54
Theratechnologies to further evaluate potential sale of the company
2025-04-13 (ET)
2025-04-13
10:43:00
Soleus Capital issues letter to board of Theratechnologies
2025-04-11 (ET)
2025-04-11
10:00:06
Future Pak submits proposals to acquire Theratechnologies
Sign Up For More Events
Sign Up For More Events
News
9.0
05-02NewsfilterTheratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
8.5
04-16SeekingAlphaTheratechnologies to further evaluate potential sale of company
8.5
04-15Yahoo FinanceTheratechnologies Provides Update on Sale Process
Sign Up For More News
People Also Watch
WMT
Walmart Inc
98.240
USD
+1.96%
AMZN
Amazon.com Inc
205.590
USD
+0.20%
AAPL
Apple Inc
211.260
USD
-0.09%
TSLA
Tesla Inc
349.980
USD
+2.09%
META
Meta Platforms Inc
640.340
USD
-0.55%
ORCL
Oracle Corp
160.490
USD
+0.68%
NVDA
NVIDIA Corp
135.400
USD
+0.42%
XOM
Exxon Mobil Corp
108.190
USD
-0.36%
AVGO
Broadcom Inc
228.610
USD
-1.73%
MSFT
Microsoft Corp
454.270
USD
+0.25%
FAQ
What is Theratechnologies Inc (THTX) stock price today?
The current price of THTX is 2.61 USD — it has decreased -0.38 % in the last trading day.
What is Theratechnologies Inc (THTX)'s business?
What is the price predicton of THTX Stock?
What is Theratechnologies Inc (THTX)'s revenue for the last quarter?
What is Theratechnologies Inc (THTX)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for Theratechnologies Inc (THTX)'s fundamentals?
How many employees does Theratechnologies Inc (THTX). have?